TMC Life Sciences Bhd (XKLS:0101) Stock Price, Trades & News

TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.

Financial Strength

5/10

Name	Current	Vs Industry
Cash-To-Debt	0.76
Equity-to-Asset	0.78
Debt-to-Equity	0.18
Debt-to-EBITDA	2.33
Interest Coverage	2.77
Piotroski F-Score	7/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	2.69	Distress Grey Safe
Beneish M-Score	-2.23	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

6/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	12.2
	3-Year EPS without NRI Growth Rate	-56.3
	3-Year FCF Growth Rate	16.7
	3-Year Book Growth Rate	1

Momentum Rank

8/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	59.19
	9-Day RSI	50.77
	14-Day RSI	45.26
	3-1 Month Momentum %	-4.17
	6-1 Month Momentum %	2.22
	12-1 Month Momentum %	6.98

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	1.82
	Quick Ratio	1.65
	Cash Ratio	1.1
	Days Inventory	43.85
	Days Sales Outstanding	55.58
	Days Payable	147.46

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	0.41
	Dividend Payout Ratio	0.22
	3-Year Dividend Growth Rate	35.7
	Forward Dividend Yield %	0.41
	5-Year Yield-on-Cost %	1.13
	Shareholder Yield %	4.06

Profitability Rank

8/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	63.48
	Operating Margin %	5.76
	Net Margin %	3.92
	EBITDA Margin %	17.34
	FCF Margin %	10.01
	OCF Margin %	15.61
	ROE %	1.77
	ROA %	1.35
	ROIC %	1.6
	3-Year ROIIC %	-89.77
	ROC (Joel Greenblatt) %	4.02
	ROCE %	2.93
	Years of Profitability over Past 10-Year	10

GF Value Rank

10/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	50
	PE Ratio without NRI	50
	Price-to-Owner-Earnings	40
	PEG Ratio	5.75
	PS Ratio	2.03
	PB Ratio	0.91
	Price-to-Tangible-Book	1.18
	Price-to-Free-Cash-Flow	21.43
	Price-to-Operating-Cash-Flow	12.86
	EV-to-EBIT	27.64
	EV-to-EBITDA	12.25
	EV-to-Revenue	2.13
	EV-to-FCF	20.78
	Price-to-GF-Value	0.73
	Price-to-Projected-FCF	1.8
	Price-to-DCF (Earnings Based)	4.5
	Price-to-DCF (FCF Based)	0.85
	Price-to-Median-PS-Value	0.44
	Price-to-Peter-Lynch-Fair-Value	4.5
	Price-to-Graham-Number	1.61
	Earnings Yield (Greenblatt) %	3.62
	FCF Yield %	4.94
	Forward Rate of Return (Yacktman) %	11.79

Financials

Annual Quarterly TTM

XKLS:0101's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

TMC Life Sciences Bhd Executives

Details

GF Value™: RM0.62

XKLS:0101

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with 0101. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil RM)	386.948
	EPS (TTM) (RM)	0.009
	Beta	1.0194
	3-Year Sharpe Ratio	-0.34
	3-Year Sortino Ratio	-0.49
	Volatility %	31.6
	14-Day RSI	45.26
	14-Day ATR (RM)	0.009391
	20-Day SMA (RM)	0.446
	12-1 Month Momentum %	6.98
	52-Week Range (RM)	0.38 - 0.575
	Shares Outstanding (Mil)	1,741.88

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	7
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

TMC Life Sciences Bhd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

TMC Life Sciences Bhd Stock Events

Financials Calendars

Event	Date	Price (RM)
MYR 0.001863 Cash Dividend	2025-12-08	0.45 (+1.12%)
MYR 0.004898 Cash Dividend	2024-12-05	0.51 (+0.00%)
MYR 0.017271 Cash Dividend	2024-12-05	0.51 (+0.00%)

Show

Entries

TMC Life Sciences Bhd Frequently Asked Questions

What is TMC Life Sciences Bhd(XKLS:0101)'s stock price today?

The current price of XKLS:0101 is RM0.45. The 52 week high of XKLS:0101 is RM0.57 and 52 week low is RM0.38.

When is next earnings date of TMC Life Sciences Bhd(XKLS:0101)?

The next earnings date of TMC Life Sciences Bhd(XKLS:0101) is .

Does TMC Life Sciences Bhd(XKLS:0101) pay dividends? If so, how much?

The Dividend Yield % of TMC Life Sciences Bhd(XKLS:0101) is 0.41% (As of Today), Highest Dividend Payout Ratio of TMC Life Sciences Bhd(XKLS:0101) was 2.5. The lowest was 0.08. And the median was 0.17. The Forward Dividend Yield % of TMC Life Sciences Bhd(XKLS:0101) is 0.41%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
No Press Release

Articles on TMC Life Sciences Bhd

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.